Covaxin

Vivek Ranjan Agnihotri is an Indian director who has struck a chord with his films and provided compelling cinema. Vivek's films have been an eye opener to society, and with 'The Kashmir Files,' he shows that he can attain enormous things.…

 New Delhi: An ICMR study has indicated that a booster dose of Covaxin is safe and necessary to ensure persistent immunity to minimise breakthrough infections of COVID-19, due to newly emerging variants, Minister of State for Health Bharati…

Pune: The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of…

New Delhi: The health ministry on Thursday refuted allegations that there were irregularities in approvals given to Bharat Biotech for the manufacture of covid-19 vaccine Covaxin. "We condemn targeted narrative against COVAXIN put forth…

Geneva: The World Health Organization said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities and address…

Hyderabad: Bharat Biotech said that it is slowing down production of its Covid-19 vaccine Covaxin across its manufacturing facilities. The company said the decision has been taken as it has completed its supply obligations to procurement…

Hyderabad: Covaxin will be evaluated as a COVID-19 vaccine candidate in the United States, said Hyderabad-based Bharat Biotech on Saturday. "Ocugen, Inc (NASDAQ: OCGN) announced that the US Food and Drug Administration (FDA) has lifted…

New Delhi: The Drugs Controller General of India (DCGI) on Thursday granted regular market approval to Serum Institute of India's (SII's) Covishield and Bharat Biotech's Covaxin for use in the adult population subject to certain conditions.…

Hyderabad: Bharat Biotech on Friday issued a statement urging healthcare workers to be “vigilant” and ensure only Covaxin is being administered to the age group of 15-18 years. “We have received several reports of other Covid-19 vaccines…

New Delhi: The Drug Controller General of India (DGCI) on Saturday approved Bharat Biotech's Covid-19 vaccine, Covaxin for emergency use authorisation in the 12-18 years age group. Bharat Biotech has submitted data from clinical trials…